Incyte advances multiple early-phase cancer trials with potential therapeutic breakthroughs, highlighting their strategic focus on oncology and rare diseases.
Becton Dickinson shares underperform, trading below fair value estimate amid risks and uncertainties.
US Vice President visits Israel to reinforce fragile ceasefire between Israel and Hamas amid ongoing challenges.
Incyte advances multiple early-phase cancer trials with potential therapeutic breakthroughs, highlighting their strategic focus on oncology and rare diseases.
Becton Dickinson shares underperform, trading below fair value estimate amid risks and uncertainties.
US Vice President visits Israel to reinforce fragile ceasefire between Israel and Hamas amid ongoing challenges.